ArticleBioorganic chemistry2026
Red-light-activated and thermally-stable amido-dithienylethenes for the reversible control of G-quadruplex binding and anticancer activity.
Article in Bioorganic chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Photo-responsive G-quadruplex (G4) ligands offer a powerful means to achieve spatiotemporal control over nucleic acid targeting, yet many existing scaffolds suffer from limited thermal stability or modest differences in affinity between photo-isomers. Here we report a thermally stable amido-pyridinium dithienylethene ligand (2) designed to enhance photo-isomer-dependent G4 recognition and increased structural modulation upon switching. Ligand 2 undergoes efficient and reversible photo-isomerization between its open and closed forms under near-UV and red-light irradiation, with long-lived photo-stationary states. Biophysical assays demonstrate that the open-isomer binds cancer-relevant G4 oligonucleotide sequences with 2-7-fold higher affinity than the closed form, while retaining high selectivity over duplex DNA. NMR studies reveal widespread perturbations across multiple G4 topologies, consistent with groove-associated interactions, and confirm that structural changes can be reversibly modulated by alternating irradiation. Importantly, the open-isomer exhibits a five-fold increase in cytotoxicity toward HeLa cells compared to the closed form, while showing negligible toxicity in healthy fibroblasts. Overall, ligand 2 represents a red-light-activated and thermally robust photo-switchable scaffold capable of reversible control over G4 binding and anticancer activity. These findings highlight the potential of amide-modified DTE frameworks as next-generation photo-responsive agents for precise regulation of G4-binding activity and anticancer activity.
Indexed as
Identifiers
41806608What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.